Premium
COVID‐19 and novel mRNA vaccines in pregnancy: an updated literature review
Author(s) -
Joubert E,
Kekeh AC,
Amin CN
Publication year - 2022
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/1471-0528.16973
Subject(s) - covid-19 , pandemic , pregnancy , medicine , scale (ratio) , coronavirus , intensive care medicine , virology , biology , geography , infectious disease (medical specialty) , cartography , disease , outbreak , genetics
The novel coronavirus, SARS‐CoV‐2, or COVID‐19, has affected the world on a pandemic scale resulting in catastrophic outcomes and deaths. Currently, there is limited safety data specific to mRNA vaccine use in pregnant or lactating individuals and the potential risks to a pregnant individual and the fetus are unknown. We report an updated literature review of current information and evidence available to aid in the decision whether to vaccinate against COVID‐19 currently being made by pregnant individuals and their healthcare providers so that they are able to make a well‐informed recommendation and decision.